Status:
TERMINATED
GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
60+ years
Brief Summary
The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the ...
Eligibility Criteria
Inclusion
- Early stage breast cancer patients taking adjuvant endocrine therapy (ie, tamoxifen, anastrozole, letrozole, exemestane).
- Age ≥ 60 years
- Must have broadband internet access at home (to enable the base for the system to communicate to the Vitality server).
- Must have a landline or mobile phone
Exclusion
- Non-English speaking patients
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01239251
Start Date
November 1 2010
End Date
November 1 2011
Last Update
March 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center 1275 York Avenue
New York, New York, United States, 10065